• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Ascendis Pharma A/S (ASND)

American Depository Receipt
Sell: $210.00|Buy: $233.00|Change: 7.09 (3.28%)

This share can be held in a Dealing account

Company profile

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Address

Tuborg Boulevard 5
Hellerup
DNK
DK-2900

Telephone

+1 650 3528389

Website

https://www.ascendispharma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Ascendis Pharma AS Fourth Quarter Earnings Conference Call for 20262027-02-11T16:30:00
Ascendis Pharma AS Fourth Quarter Earnings Results for 20262027-02-11T00:00:00
Ascendis Pharma AS Annual Report for 20262027-02-11T00:00:00
Ascendis Pharma AS Third Quarter Earnings Conference Call for 20262026-11-12T16:30:00
Ascendis Pharma AS Third Quarter Earnings Results for 20262026-11-12T00:00:00
Ascendis Pharma AS Second Quarter Earnings Conference Call for 20262026-08-07T16:30:00
Ascendis Pharma AS Second Quarter Earnings Results for 20262026-08-07T00:00:00
Ascendis Pharma AS First Quarter Earnings Conference Call for 20262026-05-01T16:30:00
Ascendis Pharma AS First Quarter Earnings Results for 20262026-05-01T00:00:00
Ascendis Pharma AS Fourth Quarter Earnings Conference Call for 20252026-02-11T16:30:00
Ascendis Pharma AS Fourth Quarter Earnings Result for 20252026-02-11T00:00:00
Ascendis Pharma AS Annual Report for 20252026-02-11T00:00:00

Previous key dates

NameKey Date
Ascendis Pharma AS Fourth Quarter Earnings Conference Call for 20252026-02-11T16:30:00
Ascendis Pharma AS Fourth Quarter Earnings Result for 20252026-02-11T00:00:00
Ascendis Pharma AS Annual Report for 20252026-02-11T00:00:00
44(th) Annual J.P. Morgan Healthcare Conference2026-01-12T10:30:00
Ascendis Pharma AS Third Quarter Earnings Conference Call for 20252025-11-12T16:30:00
Ascendis Pharma AS Third Quarter Earnings Result for 20252025-11-12T00:00:00
2025 Wells Fargo Healthcare Conference2025-09-03T08:00:00
Ascendis Pharma AS Second Quarter Earnings Conference Call for 20252025-08-07T16:30:00
Ascendis Pharma AS Second Quarter Earnings Result for 20252025-08-07T00:00:00
Ascendis Pharma AS First Quarter Earnings Conference Call for 20252025-05-01T16:30:00
Ascendis Pharma AS First Quarter Earnings Result for 20252025-05-01T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-04T11:10:00
Ascendis Pharma AS Fourth Quarter Earnings Conference Call for 20242025-02-12T16:30:00
Ascendis Pharma AS Fourth Quarter Earnings Result for 20242025-02-12T00:00:00
Ascendis Pharma AS Annual Report for 20242025-02-12T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.